Surgery Partners (SGRY) Q2 Revenue Up 8%
Surgery Partners (SGRY -0.34%), a leading operator of ambulatory surgical facilities, announced its results for the second quarter on August 5, 2025. The company reported GAAP revenue of $826.2 mil...
Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains?
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne...
Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Er...
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.
SGRY or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Surgery Partners (SGRY) or Medpace (MEDP). But which of these two stocks offers value investors a better ba...
SGRY vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Medpace (MEDP). But which of these two companies is the best option for th...
Surgery Partners, Inc. (SGRY) Q1 2024 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2024 Results Conference Call May 4, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evan...
Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced...
Surgery Partners (SGRY) Upgraded to Buy: What Does It Mean for the Stock?
Surgery Partners (SGRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Believe Surgery Partners (SGRY) Could Rally 39.04%: Here's is How to Trade
The mean of analysts' price targets for Surgery Partners (SGRY) points to a 39% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon...
Here's What Key Metrics Tell Us About Surgery Partners (SGRY) Q4 Earnings
While the top- and bottom-line numbers for Surgery Partners (SGRY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key me...
Surgery Partners (SGRY) Beats Q4 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.27 per share a year ago.
Gear Up for Surgery Partners (SGRY) Q4 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Surgery Partners (SGRY) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the est...
Why Surgery Partners (SGRY) is Poised to Beat Earnings Estimates Again
Surgery Partners (SGRY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Surgery Partners feeling no pinch from macroeconomic weakness
Surgery Partners Inc. NASDAQ: SGRY is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes surgica...
Related Companies